Nautilus Biotechnology Inc

NASDAQ NAUT

Data sourced from iex and EODHD
Download Data

Nautilus Biotechnology Inc Income Statement 2018 - 2024

This table shows the Income Statement for Nautilus Biotechnology Inc going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31
Revenue
M 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - -
Cost of Revenue
M 2 2 2 1 1 1 - - - - - - - - - - - - - - - -
Gross Profit
M -2 7 -2 -1 -1 -1 - - - - - - - - - - - - - - - -
Operating Expenses
M 20 24 14 14 17 16 - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 9 8 7 7 7 7 6 7 6 7 6 4 4 1 1 1 4 0 0 0 0 112
Research and Development (R&D) Expenses
M 12 12 12 12 11 10 10 9 10 10 8 6 5 4 3 3 - - - - - -
Other Operating Expenses
M -1 4 -5 -5 -1 0 - - - - - - - - - - - - - - - -
Costs and Expenses
M 18 18 18 18 17 15 - - - - - - - - - - - - - - - -
Operating Income
M -22 -17 -16 -16 -18 -17 -16 -15 -16 -17 -15 -11 -8 -5 -4 -3 -4 0 0 0 0 -112
Interest Expense
M - 3 - 3 -3 3 2 1 0 - - - - - - - - - - - - -
Non-operating Income/Expense
M 3 0 3 0 3 4 2 1 0 0 0 0 0 0 0 0 1 1 1 1 1 738
EBT
M -19 -17 -16 -16 -15 -13 -14 -15 -16 -17 -15 -11 -8 -5 -4 -3 -3 0 1 1 1 627
Income Tax Provision
M - -3 3 -3 -3 3 2 -1 0 - -1 - - - - - - - - - - -
Income after Tax
M - -14 -19 -13 -12 -16 -16 -14 -16 - -14 - - - - - - - - - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 -5 -4 -3 - - - - - -
Net Income
M - - - -16 -15 -13 -14 -15 -16 -23 -15 -11 -8 0 0 0 -3 - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 125,135,451.00 124,984,918.00 124,933,837.00 124,603,181.00 124,590,351.00 124,789,542.00 124,651,318.00 124,494,036.00 124,418,580.00 124,232,794.00 124,114,893.00 55,070,480.00 124,045,255.00 19,186,500.00 124,045,255.00 124,045,255.00 14,375,000.00 14,375,000.00 14,375,000.00 14,375,000.00 14,375,000.00 14,375,000.00
EBITDA
M -20 -18 -19 -18 -17 -16 -15 -15 -15 -16 -15 -10 -8 -5 -3 -3 -3 0 1 1 1 627
Depreciation and Amortization
M 2 2 -3 1 1 1 1 1 1 1 1 1 1 1 1 - 1 1 1 1 1 738
EBIT
M -22 -20 -16 -19 -18 -17 -16 -15 -16 -17 -15 -11 -8 -5 -4 -3 -4 0 0 0 0 -112
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - 17.82 -20.13 20.38 20.68 -21.52 -13.43 5.33 1.64 - 5.06 - - - - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - -
Gross Profit Margin
% - 80.64 - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - -207.31 - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - -224.20 - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - -243.56 - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - -207.31 - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email